These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 6179887)

  • 21. A comparison of the anti-anaphylactic activities of salbutamol and disodium cromoglycate in the rat, the rat mast cell and in human lung tissue.
    Butchers PR; Fullarton JR; Skidmore IF; Thompson LE; Vardey CJ; Wheeldon A
    Br J Pharmacol; 1979 Sep; 67(1):23-32. PubMed ID: 115530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of disodium cromoglycate on cutaneous basophil anaphylaxis.
    Golden HW; Crean GL; Iacuzio DA; Otterness IG
    J Immunol; 1986 Sep; 137(5):1495-503. PubMed ID: 2427571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunopharmacologic properties of WY-16, 922, a new orally effective antiallergic agent.
    Rosenthale ME; Begany AJ; Dervinis A; Sellstedt J; Guinosso C; Gluckman MI
    J Pharmacol Exp Ther; 1976 Jun; 197(3):725-33. PubMed ID: 58988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mast cells and basophils: models for studying the antianaphylactic potency of drugs.
    Wahn U; Müller J
    Pediatr Pharmacol (New York); 1983; 3(3-4):287-92. PubMed ID: 6204269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selected immunologic properties of tiprinast, a non-steroidal antiallergy agent.
    Gillespie E; Dungan KW; Gomoll AW; Seidehamel RJ
    Int J Immunopharmacol; 1985; 7(5):655-60. PubMed ID: 2412976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The inhibition of histamine release by antiallergic drugs.
    Nagai H; Kelly K; Sehon AH
    Int Arch Allergy Appl Immunol; 1978; 56(4):307-15. PubMed ID: 75849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A protective action of disodium cromoglycate against the contraction of guinea-pig ileum induced by various pharmacological stimulants.
    Kazimierczak W; Gonzalez Alvarez R; Maśliński C
    Agents Actions; 1980 Apr; 10(1 Pt 2):8-14. PubMed ID: 6155773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiallergic properties of SQ 13,847, an orally effective agent. II. Activity in vitro.
    Free CA; Hall LE
    J Pharmacol Exp Ther; 1980 Jun; 213(3):437-40. PubMed ID: 6162946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiallergic action of disodium cromoglycate and xanthone RS 7540.
    Gonzalez Alvarez R; Kazimierczak W
    Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):333-9. PubMed ID: 6135406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The anti-anaphylactic action of tiaramide hydrochloride.
    Renoux ML; Weill BJ; Wallach D; Chwetzoff E
    Allergy; 1978 Apr; 33(2):76-81. PubMed ID: 80140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benzopyrones. 14. Synthesis and antiallergic properties of some N-tetrazolylcarboxamides and related compounds.
    Ellis GP; Becket GJ; Shaw D; Wilson HK; Vardey CJ; Skidmore IF
    J Med Chem; 1978 Nov; 21(11):1120-6. PubMed ID: 82617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The mode of action of antianaphylactic effect of tiaramide hydrochloride.
    Takashima T; Ono T; Ohtsuka M; Mori J; Kumada S
    Arzneimittelforschung; 1979; 29(6):903-10. PubMed ID: 90511
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of traxanox sodium on SRS-A release in bronchial and peritoneal anaphylaxis].
    Terasawa M; Imayoshi T; Goto K
    Nihon Yakurigaku Zasshi; 1983 Jul; 82(1):93-101. PubMed ID: 6194083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiallergic/antiasthmatic effect of novel antiallergic hexapeptide-95/220 in various experimental models.
    Singh R; Nath A; Gupta PP; Shukla M; Khare SK; Kundu B
    Indian J Exp Biol; 2001 Sep; 39(9):871-7. PubMed ID: 11831367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of antianaphylactic agents on substance-P induced histamine release from rat peritoneal mast cells.
    Hachisuka H; Nomura H; Sakamoto F; Mori O; Okubo K; Sasai Y
    Arch Dermatol Res; 1988; 280(3):158-62. PubMed ID: 2454082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1,2,4-Triazolo[4,3-a]quinoxaline-1,4-diones as antiallergic agents.
    Loev B; Musser JH; Brown RE; Jones H; Kahen R; Huang FC; Khandwala A; Sonnino-Goldman P; Leibowitz MJ
    J Med Chem; 1985 Mar; 28(3):363-6. PubMed ID: 2579236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of allergic histamine release from rat peritoneal mast cells by azelastine. Interaction with selected antiasthmatic drugs.
    Chand N; Pillar J; Diamantis W; Sofia RD
    Int Arch Allergy Appl Immunol; 1988; 86(3):256-60. PubMed ID: 2456990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological study of phospholipase A2-induced histamine release from rat peritoneal mast cells.
    Choi SH; Sakamoto T; Fukutomi O; Inagaki N; Matsuura N; Nagai H; Koda A
    J Pharmacobiodyn; 1989 Sep; 12(9):517-22. PubMed ID: 2482349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of disodium cromoglycate on mast cell-mediated immediate-type allergic reactions.
    Shin HY; Kim JS; An NH; Park RK; Kim HM
    Life Sci; 2004 Apr; 74(23):2877-87. PubMed ID: 15050425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An antiallergic activity of disodium cromoglycate unrelated to mast cell activation.
    Kuriyama K; Hiyama Y; Nagatahira R; Okuda T; Saito K; Ito K
    Agents Actions; 1986 Aug; 18(5-6):473-8. PubMed ID: 2429526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.